Efficacy of first-line (1L) nivolumab (N) plus ipilimumab (I) by tumor histologic subtype in patients (pts) with metastatic nonsquamous NSCLC (mNSQ-NSCLC) Meeting Abstract
| Authors: | Borghaei, H.; Balli, D.; Paz-Ares, L.; Reck, M.; Ramalingam, S. S.; Brahmer, J. R.; Ciuleanu, T. E.; Pluzanski, A.; Lee, J. S.; Gainor, J.; Schenker, M.; Schoenfeld, A.; Caro, R. B.; Ready, N.; Lee, K. H.; Zurawski, B.; Audigier-Valette, C.; Baxi, V.; Geese, W.; O'Byrne, K. J. |
| Abstract Title: | Efficacy of first-line (1L) nivolumab (N) plus ipilimumab (I) by tumor histologic subtype in patients (pts) with metastatic nonsquamous NSCLC (mNSQ-NSCLC) |
| Meeting Title: | 2023 European Lung Cancer Congress |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 18 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2023 Mar 29-Apr 1 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-04-01 |
| Start Page: | S64 |
| End Page: | S65 |
| Language: | English |
| ACCESSION: | WOS:000995007600042 |
| PROVIDER: | wos |
| DOI: | 10.1016/s1556-0864(23)00295-2 |
| Notes: | Meeting Abstract: 41P -- Source: Wos |
